Contact US | Chinese
You Position: Home > Journal issue
Drug Evaluation Drug Evaluation

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

Drug Evaluation

Items 1-5 of 10
«Preious | of 2 |
1

Advancesinresearchonparathyroidhormonetreatmentinthepatientswithosteoporosis

Drug Evaluation, , Issue 5,2013, Pages 40-44, doi:10.3969/j.issn.1672-2809.2013.05.011

2

全面覆盖,有效干预——骨质疏松治疗药物更新

Drug Evaluation, , Issue 5,2013, Pages 14, doi:10.3969/j.issn.1672-2809.2013.05.005

3

T he prevention and treatment ofglucocorticoid-induced osteoporosis

Drug Evaluation, , Issue 5,2013, Pages 31-35, doi:10.3969/j.issn.1672-2809.2013.05.009

4

Pharmacological intervention ofosteoporotic hip fracture

Drug Evaluation, , Issue 5,2013, Pages 22-26, doi:10.3969/j.issn.1672-2809.2013.05.007

5

•文摘•

Drug Evaluation, , Issue 5,2013, Pages 8-9,

Items 1-5 of 10
«Preious | of 2 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn